A robotic system has been developed to automate the production of human mini-organs derived from stem cells. The ability to rapidly, mass produce organoids promises to expand the use of mini-organs in basic research and drug discovery. The system was tested in producing kidney organoids, including models of polycystic kidney disease. The robots were also programmed to analyze the organoids they produced.
About The Author
Our Facebook Page
amniotic stem cells Biology Biotech california stem cells California Stem Cell Treatment Center Cancer Cell Surgical Network CIRM CRISPR Daily fat stem cells fda FDA stem cells Health iPS cells Jeanne Loring Kristin Comella Leigh Turner Liveyon Medical research Pharma Research review Science Society stem cell clinic stem cell clinics stem cell law stem cell lawsuit Stem Cell News Stem Cell Research Stem cells Stem Cell Therapy stem cell treatment stem cell treatment cost Stemgenex SYN The Nutshell Top Story U.S. Stem Cell Inc Uncategorized USRM US Stem Cell Viacyte World news